<code id='5AA722BCAA'></code><style id='5AA722BCAA'></style>
    • <acronym id='5AA722BCAA'></acronym>
      <center id='5AA722BCAA'><center id='5AA722BCAA'><tfoot id='5AA722BCAA'></tfoot></center><abbr id='5AA722BCAA'><dir id='5AA722BCAA'><tfoot id='5AA722BCAA'></tfoot><noframes id='5AA722BCAA'>

    • <optgroup id='5AA722BCAA'><strike id='5AA722BCAA'><sup id='5AA722BCAA'></sup></strike><code id='5AA722BCAA'></code></optgroup>
        1. <b id='5AA722BCAA'><label id='5AA722BCAA'><select id='5AA722BCAA'><dt id='5AA722BCAA'><span id='5AA722BCAA'></span></dt></select></label></b><u id='5AA722BCAA'></u>
          <i id='5AA722BCAA'><strike id='5AA722BCAA'><tt id='5AA722BCAA'><pre id='5AA722BCAA'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:62

          Does biotech prepare you for the presidency? Who really wants to gut the FDA? And why do drug companies struggle with IT?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how Vivek Ramaswamy, fresh off his headline-grabbing debut at the first Republican presidential debate, went from a drug industry entrepreneur to a GOP rising star — and how his former biotech colleagues are reacting to it. We also explain the latest news in the life sciences, including a curious data leak and the family business of a famed biotech inventor.

          advertisement

          For more on what we cover, here’s more on Ramaswamy; here’s the news on the data leak; here’s the story on the latest Langer venture; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          comprehensive

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Questions loom on AstraZeneca cancer drug as safety concerns ebb
          Questions loom on AstraZeneca cancer drug as safety concerns ebb

          AnAstraZenecaadatESMO2023inMadrid.AndrewJoseph/STATMADRID—QuestionsaboutoneofAstraZeneca’skeycancerd

          read more
          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

          1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

          read more

          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates